ROMANIELLO, DONATELLA
 Distribuzione geografica
Continente #
EU - Europa 712
NA - Nord America 698
AS - Asia 224
AF - Africa 16
SA - Sud America 1
Totale 1.651
Nazione #
US - Stati Uniti d'America 696
IT - Italia 364
SG - Singapore 142
IE - Irlanda 84
DE - Germania 63
SE - Svezia 60
GB - Regno Unito 53
CN - Cina 50
AT - Austria 16
BG - Bulgaria 13
FI - Finlandia 12
ES - Italia 11
JO - Giordania 10
NL - Olanda 10
CH - Svizzera 9
TG - Togo 9
CI - Costa d'Avorio 7
FR - Francia 7
IR - Iran 6
DK - Danimarca 4
IN - India 4
HK - Hong Kong 3
BD - Bangladesh 2
BE - Belgio 2
IL - Israele 2
TW - Taiwan 2
BR - Brasile 1
CA - Canada 1
CU - Cuba 1
GR - Grecia 1
JP - Giappone 1
PL - Polonia 1
RO - Romania 1
RU - Federazione Russa 1
TR - Turchia 1
UZ - Uzbekistan 1
Totale 1.651
Città #
Bologna 196
Singapore 134
Chandler 123
Dublin 81
Princeton 72
Ashburn 41
Berlin 38
Southend 37
Fairfield 33
Medford 23
Los Angeles 19
Santa Clara 19
Milan 17
Vienna 16
Beijing 15
Seattle 15
Rome 13
Sofia 13
London 11
New York 11
Amman 10
Bremen 10
Woodbridge 10
Bern 9
Helsinki 9
Lomé 9
Olalla 9
Marcon 8
San Diego 8
Abidjan 7
Boydton 7
Cambridge 7
Florence 7
Forlì 7
Redmond 7
Reggio Emilia 7
Stanford 7
Wilmington 7
Boardman 6
Brescia 6
Modena 6
Alicante 5
Amsterdam 5
Houston 5
Naples 5
Ann Arbor 4
Bronshoj 4
Markaz 4
Turin 4
Carpi 3
Ithaca 3
Kilburn 3
Lappeenranta 3
Mérignac 3
Mülheim 3
Shanghai 3
Arzano 2
Bresso 2
Brussels 2
Campobasso 2
Caravaggio 2
Castelfranco Veneto 2
Castiglione dei Pepoli 2
Chicago 2
Columbus 2
Dhaka 2
Ferrara 2
Formigine 2
Groningen 2
Guangzhou 2
Hong Kong 2
Hyderabad 2
Imola 2
Jinan 2
Madrid 2
Montecatini Terme 2
Orzinuovi 2
Phoenix 2
Qingdao 2
Rehovot 2
Riccione 2
Taipei 2
Wageningen 2
Americana 1
Anyang 1
Bucharest 1
Bühl 1
Cankaya 1
Caprino Veronese 1
Casale sul Sile 1
Castenaso 1
Cedar Knolls 1
Chengdu 1
Chiswick 1
Civitanova Marche 1
Cogollo del Cengio 1
Des Moines 1
Ferrara di Monte Baldo 1
Frankfurt am Main 1
Girona 1
Totale 1.218
Nome #
Roles of IL-1 in Cancer: From Tumor Progression to Resistance to Targeted Therapies 115
ETS Proteins Bind with Glucocorticoid Receptors: Relevance for Treatment of Ewing Sarcoma 86
IL-1 and senescence: Friends and foe of EGFR neutralization and immunotherapy 85
CEA Cell Adhesion Molecule 6 (CEACAM6), Collagen Type I Alpha 2 Chain (COL1A2), Galectin 4 (LGALS4) and Tetraspanin 8 (TSPAN8) mRNAs as blood biomarkers for colorectal cancer 77
Senescence-associated reprogramming induced by interleukin-1 impairs response to EGFR neutralization 77
Extracellular Vesicles and Epidermal Growth Factor Receptor Activation: Interplay of Drivers in Cancer Progression 74
NRG1/ERBB3/ERBB2 Axis Triggers Anchorage-Independent Growth of Basal-like/Triple-Negative Breast Cancer Cells 70
The autocrine loop of ALK receptor and ALKAL2 ligand is an actionable target in Consensus Molecular Subtype 1 colon cancer 70
MET receptor regulates perinuclear actin cap remodeling through YAP1 inactivation 63
The autocrine loop of ALK receptor and ALKAL2 ligand is an actionable target in consensus molecular subtype 1 colon cancer 60
Aberrant MET activation impairs perinuclear actin cap organization with YAP1 cytosolic relocation 49
Neuregulin 4 Boosts the Efficacy of Anti-ERBB2 Neutralizing Antibodies 46
null 46
IL-1 Associated Post Senescence Reprogramming Impairs Response To EGFR Neutralization 40
Cancer Immunotherapy: The Dawn of Antibody Cocktails 39
BMP7 promotes cardiomyocyte regeneration in zebrafish and adult mice 37
JAK2-Regulation Of HER2 “Addiction” In HER2-Positive Breast Cancer Cell Lines 35
Inhibition of a pancreatic cancer model by cooperative pairs of clinically approved and experimental antibodies 32
β-Hexachlorocyclohexane Drives Carcinogenesis in the Human Normal Bronchial Epithelium Cell Line BEAS-2B 31
Senescence-associated reprogramming impairs response to EGFR neutralization 31
Biochemical characterization of the ERp57-STAT3 complex 30
Functional Studies Of Stat3 And Its Interactors In Breast Cancer 29
First-line therapy based on kinase inhibitors and antibodies prevents resistance in egfr-mutated lung cancer. 28
Analysis of stat3 post-translational modifications (ptms) in human prostate cancer with different gleason scores 27
Comparative analysis of the interaction between different flavonoids and pdia3 27
An oligoclonal antibody durably overcomes resistance of lung cancer to third-generation EGFR inhibitors 27
MET receptor regulates perinuclear actin cap remodeling through YAP1 inactivation 27
A Combination of Approved Antibodies Overcomes Resistance of Lung Cancer to Osimertinib by Blocking Bypass Pathways 25
Upfront admixing antibodies and EGFR inhibitors preempts sequential treatments in lung cancer models 23
PDL1 immunohistochemistry in canine neoplasms: Validation of commercial antibodies, standardization of evaluation, and scoring systems 22
Dangerous liaison: organochlorine substances, energy metabolism and cancer 22
The natural sesquiterpene β- caryophyllene acts as an enviromental decontaminant through the interference with the STAT3 signalling pathway 22
Synergy Between Kinase Inhibitors And Antibodies Enables Upfront Prevention Of Recurring Secondary Resistance In Egfr-Mutated Lung Cancer 21
Acetylation and phosphorylation of STAT3 are involved in the responsiveness of microglia to beta amyloid 21
PARP-1 as coactivator of STAT3 in M14 melanoma cell line 21
Targeting anaplastic lymphoma kinase in consensus molecular subtype 1 colon cancer patients 20
Targeting HER3, a Catalytically Defective Receptor Tyrosine Kinase, Prevents Resistance of Lung Cancer to a Third-Generation EGFR Kinase Inhibitor 19
STAT3 post-translational modifications drive cellular signaling pathways in prostate cancer cells 18
EGFR/STAT3/ERp57 Interplay in human prostate cancer progression 18
Interaction between flavonoids and PDIA3 18
Senescence-associated reprogramming impairs response to EGFR neutralization 16
L858R emerges as a potential biomarker predicting response of lung cancer models to anti-EGFR antibodies: Comparison of osimertinib vs. cetuximab 15
β-Caryophyllene Counteracts Chemoresistance Induced by Cigarette Smoke in Triple-Negative Breast Cancer MDA-MB-468 Cells 13
Protease, an Advance Therapeutic Target in Cancer 13
STAT3/ERP57/TPX2 axis and process of “androgen escape” in prostate cancer 13
STAT3-EGFR PATHWAY IN NEUROENDOCRINE PROSTATE CANCER: A CASE REPORT 12
STAT3--ERp57 Interplay in human prostate cancer 11
STAT3's role in microglial cells 11
A bispecific antibody targeting EGFR and AXL delays resistance to osimertinib 4
null 4
null 1
Totale 1.741
Categoria #
all - tutte 7.565
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.565


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202029 0 0 0 0 0 0 3 14 7 2 1 2
2020/202171 3 19 24 0 3 3 6 1 4 3 1 4
2021/2022310 0 3 0 0 3 3 1 36 45 18 123 78
2022/2023664 56 62 27 61 74 56 17 61 131 10 56 53
2023/2024373 44 44 36 30 22 67 14 27 14 28 16 31
2024/2025294 34 186 74 0 0 0 0 0 0 0 0 0
Totale 1.741